ABSTRACT
The Accudep technology has been developed to address several issues in the design and manufacture of a range of dosage forms, including those for oral administration. This technology is being applied to a range of product areas including immediate-release dosage forms, super generic products, and novel controlled-release formulations. This chapter describes the recent advances made using the Accudep process to create the latter, namely controlled-release dosage forms. Specifically, this chapter covers (a) the Accudep process, (b) its application to the creation of oral modified-release (controlled-release) dosage forms, and (c) data collected from in vitro and in vivo studies.
